ADRX: ADARx Pharmaceuticals, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
13 open-market buys totaling $87.75M and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 67 | ADRX | ADARx Pharmaceuticals, Inc. | Sr One Capital Management, Llc | 10% Owner | 2026-09-28 | $10.07M | 12% | 5 insiders |
| 70 | ADRX | ADARx Pharmaceuticals, Inc. | Sr One Capital Management, Llc | 10% Owner | 2026-09-28 | $7.05M | 27% | 5 insiders |
| 74 | ADRX | ADARx Pharmaceuticals, Inc. | Sr One Capital Management, Llc | 10% Owner | 2026-09-28 | $10.07M | new | 5 insiders |
| 69 | ADRX | ADARx Pharmaceuticals, Inc. | George Simeon | Director | 2026-09-28 | $10.07M | 12% | 5 insiders |
| 72 | ADRX | ADARx Pharmaceuticals, Inc. | George Simeon | Director | 2026-09-28 | $7.05M | 27% | 5 insiders |
| 76 | ADRX | ADARx Pharmaceuticals, Inc. | George Simeon | Director | 2026-09-28 | $10.07M | new | 5 insiders |
| 60 | ADRX | ADARx Pharmaceuticals, Inc. | Chimovits Erez | Director | 2026-09-28 | $1.05M | 1% | 5 insiders |
| 65 | ADRX | ADARx Pharmaceuticals, Inc. | Gordon Carl L | Director | 2026-09-28 | $5.10M | 2% | 5 insiders |
| 60 | ADRX | ADARx Pharmaceuticals, Inc. | Gordon Carl L | Director | 2026-09-28 | $1.05M | 1% | 5 insiders |
| 76 | ADRX | ADARx Pharmaceuticals, Inc. | Gordon Carl L | Director | 2026-09-28 | $10.00M | new | 5 insiders |
| 65 | ADRX | ADARx Pharmaceuticals, Inc. | Orbimed Advisors Llc / Orbimed Capital Gp Vii Llc / Orbimed Israel Gp Ii, L.P. / Orbimed Advisors Israel Ii Ltd / Orbimed Genesis Gp Llc | Director | 2026-09-28 | $5.10M | 2% | 5 insiders |
| 60 | ADRX | ADARx Pharmaceuticals, Inc. | Orbimed Advisors Llc / Orbimed Capital Gp Vii Llc / Orbimed Israel Gp Ii, L.P. / Orbimed Advisors Israel Ii Ltd / Orbimed Genesis Gp Llc | Director | 2026-09-28 | $1.05M | 1% | 5 insiders |
| 76 | ADRX | ADARx Pharmaceuticals, Inc. | Orbimed Advisors Llc / Orbimed Capital Gp Vii Llc / Orbimed Israel Gp Ii, L.P. / Orbimed Advisors Israel Ii Ltd / Orbimed Genesis Gp Llc | Director | 2026-09-28 | $10.00M | new | 5 insiders |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.